Purchase Order 15DDHQ26P00000474
- Not listed
- The Drug Enforcement Administration (DEA) awarded a purchase order valued at $15,000 to Mark Rubenstein, M.D., P.A. for expert medical consulting services. The contract, effective February 10, 2026 through February 9, 2027, was awarded without set-aside designation on a competitive basis under a labor-hours pricing structure. The awardee, based in Jupiter, Florida, is a for-profit medical practice specializing in expert witness and pharmaceutical consulting services to federal law enforcement...
- The U.S. Drug Enforcement Administration (DEA) awarded a $19,800.00 purchase order contract to Mark Rubenstein, M.D., P.A., a medical practice and consulting firm, to provide expert witness services. The contract is for labor hours and does not have a set-aside designation, indicating the firm competed for the award in the open market. Dr. Rubenstein, the practice's lead, will leverage his specialized medical and pharmaceutical expertise to support federal investigations and prosecutions related...
- This federal contract award is for expert medical and pharmaceutical consulting services provided by Mark Rubenstein, M.D., P.A. to the Department of Justice (DOJ) Drug Enforcement Administration (DEA) over a one-year period of performance. The contract has a potential value of $18,000.00 and is a labor-hour type contract to support DEA investigations and prosecutions of drug crimes. The award does not indicate the use of any set-asides. Based on the description, Dr. Rubenstein appears to be a...
- This is a $8,400 purchase order contract awarded by the Drug Enforcement Administration (DEA), a civilian U.S. government agency, to Mark Rubenstein, M.D., P.A., a for-profit medical practice and consulting firm located in Jupiter, Florida. The contract is for Dr. Rubenstein to provide expert witness and professional medical support services to the DEA, including comprehensive medical record reviews, prescription analysis, testimony preparation, and on-site consultations to support DEA and...
- This federal contract award is for a subject matter expert, Dr. Mark Rubenstein, M.D., to provide specialized medical and pharmaceutical consulting services to the U.S. Drug Enforcement Administration (DEA). The contract, with a ceiling value of $24,000.00, covers the period from March 10, 2025 to March 9, 2026, with a final completion date of March 24, 2026. The contract requires Dr. Rubenstein, who operates a for-profit medical practice and consulting firm based in Jupiter, Florida, to support...
- The U.S. Department of Justice's Criminal Division awarded a $53,000 purchase order to Mark Rubenstein, M.D., P.A. for expert witness services. This time-and-materials contract, with an ultimate completion date of October 1, 2026, engages Dr. Rubenstein to provide specialized medical consulting and expert testimony in support of federal investigations and prosecutions. The contract was awarded without set-aside designation on October 2, 2025, and will be performed in Jupiter, Florida. As a...
- The Department of Justice Drug Enforcement Administration awarded a $1,700 purchase order to Steven Lobel MD LLC of Roswell, Georgia for expert opinion services related to investigation case number G9-23-2032/HCN1R. The firm fixed price contract runs from September 14, 2023 through September 13, 2024 and calls for the prime contractor to provide expert opinion and analysis to support the specified DEA investigation. No major subcontractors or set aside designations were identified. The award...
- The Department of Justice Drug Enforcement Administration awarded a $1,700 purchase order to Steven Lobel MD LLC of Roswell, Georgia. The contract is for expert opinion for administrative and criminal investigations to support DOJ DEA programs from August 2023 through August 2024. The firm fixed price contract calls for the prime contractor, Steven Lobel MD LLC, to provide expert consulting services relating to investigations for one year from the date of award. No subcontractors or additional...
- The Drug Enforcement Administration (DEA) awarded a $5,150 purchase order contract to Steven Lobel MD LLC on January 10, 2025, for subject matter expert (SME) funding supporting Dr. Steven Lobel. The contract, which runs through January 9, 2026, carries no set-aside designation and was awarded on a labor hours pricing basis. Steven Lobel MD LLC is a Roswell, Georgia-based medical and forensic services firm specializing in expert witness and investigative support for federal law enforcement...
- This is a $1,700 firm fixed-price purchase order contract awarded by the Drug Enforcement Administration (DEA) to Steven Lobel MD LLC, a for-profit organization based in Roswell, Georgia. The contract is for the provision of expert medical and forensic services to support DEA administrative and criminal investigations related to controlled substances. The contract has an ultimate completion date of September 10, 2024 and was awarded on September 11, 2023. The company has extensive experience...
The Drug Enforcement Administration (DEA) awarded a $18,000 purchase order to Mark Rubenstein, M.D., P.A., a medical consulting practice based in Jupiter, Florida, for expert medical and pharmaceutical consulting services. The contract, which runs from April 16, 2026 through April 15, 2027, is structured as a labor-hours purchase order with no set-aside designation, indicating it was awarded competitively based on Dr. Rubenstein's specialized expertise. Under this contract, Dr. Rubenstein will provide services including medical record reviews, prescription analyses, expert witness testimony preparation, and on-site consultations to support federal drug enforcement investigations and prosecutions. Dr. Rubenstein's firm specializes in evaluating the medical necessity and legitimacy of prescriptions, assessing patient profiles, and delivering expert medical opinions to support federal law enforcement operations. The DEA has consistently engaged Dr. Rubenstein for similar expert witness services through recurring purchase orders, reflecting an ongoing federal need for specialized medical consulting in complex drug-related investigations. The award represents typical engagement patterns for the firm, which regularly provides critical expert analysis to support federal criminal investigations and legal proceedings related to pharmaceutical and drug crimes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.0k | 4/15/26 |